Mechanisms of distal axonal degeneration in peripheral neuropathies

CR Cashman, A Höke - Neuroscience letters, 2015 - Elsevier
Peripheral neuropathy is a common complication of a variety of diseases and treatments,
including diabetes, cancer chemotherapy, and infectious causes (HIV, hepatitis C, and …

[HTML][HTML] Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

TJC Phillips, CL Cherry, S Cox, SJ Marshall, ASC Rice - PloS one, 2010 - journals.plos.org
Background Significant pain from HIV-associated sensory neuropathy (HIV-SN) affects∼
40% of HIV infected individuals treated with antiretroviral therapy (ART). The prevalence of …

Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations

BAI Payne, IJ Wilson, CA Hateley, R Horvath… - Nature …, 2011 - nature.com
There is emerging evidence that people with successfully treated HIV infection age
prematurely, leading to progressive multi-organ disease, but the reasons for this are not …

Assessment of neuropathic pain in primary care

ML Haanpää, MM Backonja, MI Bennett… - The American journal of …, 2009 - Elsevier
Management of patients presenting with chronic pain is a common problem in primary care.
Essentially, the classification of chronic pain falls into 3 broad categories:(1) pain owing to …

Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study

P Vivithanaporn, G Heo, J Gamble, HB Krentz, A Hoke… - Neurology, 2010 - AAN Enterprises
Background: Combination antiretroviral therapy (cART) has improved the survival of patients
with HIV/AIDS but its impact remains uncertain on the changing prevalence and incidence of …

[HTML][HTML] Neurologic complications of HIV disease and their treatment

SL Letendre, RJ Ellis, BM Ances… - Topics in HIV medicine …, 2010 - ncbi.nlm.nih.gov
Findings on the nervous system complications of HIV disease and their impact on people
living with HIV continue to accumulate. New reports at the 17 th Conference on Retroviruses …

Peripheral neuropathy in HIV: prevalence and risk factors

SR Evans, RJ Ellis, H Chen, T Yeh, AJ Lee, G Schifitto… - Aids, 2011 - journals.lww.com
Objectives: To estimate neuropathic sign/symptom rates with initiation of combination
antiretroviral therapy (cART) in HIV-infected ART-naive patients, and to investigate risk …

Neurological and psychiatric adverse effects of antiretroviral drugs

MS Abers, WX Shandera, JS Kass - CNS drugs, 2014 - Springer
Antiretroviral drugs are associated with a variety of adverse effects on the central and
peripheral nervous systems. The frequency and severity of neuropsychiatric adverse events …

Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?

J Underwood, KR Robertson, A Winston - Aids, 2015 - journals.lww.com
Whilst effective antiretroviral therapy is protective against the more severe forms of HIV-
associated brain disease, there remains a large burden of clinically symptomatic cognitive …

[HTML][HTML] HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain

F Denk, W Huang, B Sidders, A Bithell, M Crow, J Grist… - Pain®, 2013 - Elsevier
Histone deacetylase inhibitors (HDACIs) interfere with the epigenetic process of histone
acetylation and are known to have analgesic properties in models of chronic inflammatory …